Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related
Journal of Neuromuscular Diseases · 2025
DOI: 10.1177/22143602251323629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2025. Verfasst von Andrea Valls und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Diseases Group, Neurosciences Area, Biogipuzkoa Health Research Institute, San Sebastian, Spain. Hauptthemen laut MEDLINE: Connectin, Muscular Dystrophies, Limb-Girdle, Calpain, Muscle Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III, Association Française contre les Myopathies, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas.
Abstract (Originalsprache)
We aimed to investigate the validity of urinary N-terminal titin (TTN) fragment as a biomarker for limb-girdle muscular dystrophy LGMDR1-calpain 3 related. Thirteen LGMDR1 patients and eleven healthy controls were enrolled for the study. LGMDR1 patients had significantly increased urinary N-terminal titin fragment concentrations than age-matched controls. Even if urinary level of titin decreased with aging, it was still high in wheelchair bound patients. Thus, our findings indicate that urinary N-terminal titin fragment is a non-invasive measure of muscle damage in LGMDR1, which could be used in disease monitoring in clinical trials even in wheelchair-bound patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuromuscular Diseases Group, Neurosciences Area, Biogipuzkoa Health Research Institute, San Sebastian, Spain.
- CIBERNED, CIBER, Spanish Ministry of Science & Innovation, Carlos III Health Institute, Madrid, Spain.
- Molecular Diagnostics Platform, Biogipuzkoa Health Research Institute, San Sebastian, Spain.
- Department of Neurology, Donostialdea Integrated Health Organisation, Osakidetza, San Sebastian, Spain.
- Department of Neurosciences, University of the Basque Country UPV-EHU, San Sebastian, Spain.
- Faculty of Medicine, University of Deusto, Bilbao, Spain.
ORCID-Profile: Amets Sáenz
Förderung
- Instituto de Salud Carlos III
- Association Française contre les Myopathies
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Association of Neuromuscular diseases of Gipuzkoa
- Department of Health of the Government of the Basque Country
Zitieren
APA
Valls, A., Ruiz-Roldán, C., Immanuel, J., Camaño, P., Poza, J. J., Fernández-Torrón, R., López de Munain, A., & Sáenz, A. (2025). Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related. Journal of Neuromuscular Diseases. https://doi.org/10.1177/22143602251323629
Vancouver
Valls A, Ruiz-Roldán C, Immanuel J, Camaño P, Poza JJ, Fernández-Torrón R, et al. Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related. Journal of Neuromuscular Diseases. 2025. doi:10.1177/22143602251323629
BibTeX
@article{Valls2025,
author = {Valls, Andrea and Ruiz-Roldán, Cristina and Immanuel, Jenita and Camaño, Pilar and Poza, Juan José and Fernández-Torrón, Roberto and López de Munain, Adolfo and Sáenz, Amets},
title = {Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related},
journal = {Journal of Neuromuscular Diseases},
year = {2025},
doi = {10.1177/22143602251323629}
}
EUVIMED